Fensterle Joachim, Aicher Babette, Seipelt Irene, Teifel Michael, Engel Juergen
Aeterna Zentaris, Weismuellerstr. 50, 60314 Frankfurt, Germany.
Anticancer Agents Med Chem. 2014 May;14(4):629-35. doi: 10.2174/1871520614666140309225912.
Perifosine treatment exhibits a complex molecular response including the inhibition of Akt or the induction of apoptosis via clustering of death receptors in lipid rafts. However, the molecular response can vary between different tumor entities and the contribution of each target pathway to the activity of Perifosine might be distinct depending on the tumor entity or the agent combined with Perifosine. In this review we discuss the current view on the mechanism of action of perifosine in cancer and the contribution of the molecular targets of Perifosine to its activity.
哌立福新治疗呈现出复杂的分子反应,包括抑制Akt或通过脂筏中死亡受体的聚集诱导细胞凋亡。然而,不同肿瘤实体之间的分子反应可能有所不同,并且根据肿瘤实体或与哌立福新联合使用的药物,每个靶标途径对哌立福新活性的贡献可能也不同。在本综述中,我们讨论了目前关于哌立福新在癌症中的作用机制的观点以及哌立福新分子靶标对其活性的贡献。